The efficiency of chronic treatment with beclometasone dipropionate in patients with bronchial asthma
Abstract
The efficiency of chronic treatment with beclometasone dipropionate was assessed in 10 asthmatic subjects aged 20—45 years in stable condition. Beclometasone dipropionate — Becotide (GlaxoWellcome, England) was inhaled in a dose of 400 meg daily during 11 weeks.
Regular treatment with beclometasone dipropionate in asthmatic patients showed the significant benefit of lung function parameters and reduced airway responsiveness (log PC20 to histamine increased by 1.96 mgxm-1, beclometasone dipropionate caused a mean 49-fold increase in PC20 to histamine).
Chronic treatment with beclometasone dipropionate in asthmatic patients is highly effective in clinical practice.
About the Authors
A. V. CherniakRussian Federation
G. M. Sakharova
Russian Federation
A. G. Chuchalin
Russian Federation
References
1. Clobal Initiative for Asthma. Global Strategy for Asthma Management and Prevention N H LB I/W H O Workshop Report. 1993 (National Heart, Lung and Blood Institute of Health. January 1995).— Bethesda, 1995.
2. Juniper E.F., Cockcroft D.W., Hargreave F.E. Histamine and Methacholine Inhalation Test: Tidal Breathing Method. Laboratory Procedure and Standardisation. Lund: A B Draco, 1991.
3. Reed C.E. Aerosol glucocorticoid treatment of asthma. Adults.// Am. Rev. Respir. Dis.— 1990.— Vol.141.— P.S82—S88.
4. Quanjer Ph.H., Tammeling G.L., Cotes J.E., Pedersen O.F., Peslin R. Lung volumes and ventilatory flows / / Eur. Respir. J.— 1993.— Vol.6.— P.4—40.
5. Sterk P.J., Fabbri L.M., Quanjer Ph.H., Cockcroft D.W., O’Byrne P.M., Anderson S.D., Juniper E.F., Malo J.-L. Airway responsiveness / / Ibid.— Suppl.6.— P.55—64.
Review
For citations:
Cherniak A.V., Sakharova G.M., Chuchalin A.G. The efficiency of chronic treatment with beclometasone dipropionate in patients with bronchial asthma. PULMONOLOGIYA. 1998;(3):77-80. (In Russ.)